311 related articles for article (PubMed ID: 25339095)
21. [Lymphoproliferative disorders and inborn errors of immunity].
Doi T; Okada S
Rinsho Ketsueki; 2020; 61(9):1365-1372. PubMed ID: 33162537
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic stem cell transplantation conditioning with use of rituximab in EBV related lymphoproliferative disorders.
Shamriz O; Vilk SR; Wolf DG; Ta-Shma A; Averbuch D; Weintraub M; Stepensky P
Clin Immunol; 2014 Apr; 151(2):79-83. PubMed ID: 24584040
[TBL] [Abstract][Full Text] [Related]
23. Signaling of the ITK (interleukin 2-inducible T cell kinase)-SYK (spleen tyrosine kinase) fusion kinase is dependent on adapter SLP-76 and on the adapter function of the kinases SYK and ZAP70.
Hussain A; Mohammad DK; Gustafsson MO; Uslu M; Hamasy A; Nore BF; Mohamed AJ; Smith CI
J Biol Chem; 2013 Mar; 288(10):7338-50. PubMed ID: 23293025
[TBL] [Abstract][Full Text] [Related]
24. IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach.
Stepensky P; Weintraub M; Yanir A; Revel-Vilk S; Krux F; Huck K; Linka RM; Shaag A; Elpeleg O; Borkhardt A; Resnick IB
Haematologica; 2011 Mar; 96(3):472-6. PubMed ID: 21109689
[TBL] [Abstract][Full Text] [Related]
25. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
26. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.
Smith MC; Cohen DN; Greig B; Yenamandra A; Vnencak-Jones C; Thompson MA; Kim AS
Int J Clin Exp Pathol; 2014; 7(9):5738-49. PubMed ID: 25337215
[TBL] [Abstract][Full Text] [Related]
27. Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.
Guo W; Liu R; Ono Y; Ma AH; Martinez A; Sanchez E; Wang Y; Huang W; Mazloom A; Li J; Ning J; Maverakis E; Lam KS; Kung HJ
Mol Pharmacol; 2012 Nov; 82(5):938-47. PubMed ID: 22899868
[TBL] [Abstract][Full Text] [Related]
28. Immunological aspects of Epstein-Barr virus infection.
Ohga S; Nomura A; Takada H; Hara T
Crit Rev Oncol Hematol; 2002 Dec; 44(3):203-15. PubMed ID: 12467961
[TBL] [Abstract][Full Text] [Related]
29. itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2.
Siliciano JD; Morrow TA; Desiderio SV
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11194-8. PubMed ID: 1280821
[TBL] [Abstract][Full Text] [Related]
30. Primary Immunodeficiencies Associated with EBV Disease.
Cohen JI
Curr Top Microbiol Immunol; 2015; 390(Pt 1):241-65. PubMed ID: 26424649
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus: dermatologic associations and implications: part II. Associated lymphoproliferative disorders and solid tumors.
Eminger LA; Hall LD; Hesterman KS; Heymann WR
J Am Acad Dermatol; 2015 Jan; 72(1):21-34; quiz 35-6. PubMed ID: 25497918
[TBL] [Abstract][Full Text] [Related]
32. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary lymphomatoid granulomatosis in Griscelli syndrome type 2.
Szczawinska-Poplonyk A; Kycler Z; Breborowicz A; Klaudel-Dreszler M; Pac M; Zegadlo-Mylik M; Langfort R
Viral Immunol; 2011 Dec; 24(6):471-3. PubMed ID: 22111599
[TBL] [Abstract][Full Text] [Related]
35. A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America.
Coffey AM; Lewis A; Marcogliese AN; Elghetany MT; Punia JN; Chang CC; Allen CE; McClain KL; Gaikwad AS; El-Mallawany NK; Curry CV
Pediatr Blood Cancer; 2019 Aug; 66(8):e27798. PubMed ID: 31099136
[TBL] [Abstract][Full Text] [Related]
36. Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Zhizhuo H; Junmei X; Yuelin S; Qiang Q; Chunyan L; Zhengde X; Kunling S
Pediatr Blood Cancer; 2012 Mar; 58(3):410-4. PubMed ID: 21674762
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-2-Inducible T-Cell Kinase Deficiency Impairs Early Pulmonary Protection Against
Huang L; Ye K; McGee MC; Nidetz NF; Elmore JP; Limper CB; Southard TL; Russell DG; August A; Huang W
Front Immunol; 2019; 10():3103. PubMed ID: 32038633
[TBL] [Abstract][Full Text] [Related]
38. Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency.
Alkhairy OK; Perez-Becker R; Driessen GJ; Abolhassani H; van Montfrans J; Borte S; Choo S; Wang N; Tesselaar K; Fang M; Bienemann K; Boztug K; Daneva A; Mechinaud F; Wiesel T; Becker C; Dückers G; Siepermann K; van Zelm MC; Rezaei N; van der Burg M; Aghamohammadi A; Seidel MG; Niehues T; Hammarström L
J Allergy Clin Immunol; 2015 Sep; 136(3):703-712.e10. PubMed ID: 25843314
[TBL] [Abstract][Full Text] [Related]
39. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
[TBL] [Abstract][Full Text] [Related]
40. Novel ZAP-70-Related Immunodeficiency Presenting with Epstein-Barr Virus Lymphoproliferative Disorder and Hemophagocytic Lymphohistiocytosis.
Forster M; Moran T; Beaven A; Voorhees T
Case Reports Immunol; 2021; 2021():6587323. PubMed ID: 34239742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
